[HTML][HTML] Current status of lymphangiogenesis: molecular mechanism, immune tolerance, and application prospect

H Deng, J Zhang, F Wu, F Wei, W Han, X Xu, Y Zhang - Cancers, 2023 - mdpi.com
Simple Summary Lymphatic vessels are low-pressure, blind-ended tubular structures
essential in maintaining tissue fluid homeostasis, immune cell transport, and lipid transport …

Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect

H Deng, J Zhang, F Wu, F Wei, W Han, X Xu… - …, 2023 - search.proquest.com
The lymphatic system is a channel for fluid transport and cell migration, but it has always
been controversial in promoting and suppressing cancer. VEGFC/VEGFR3 signaling has …

Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect.

H Deng, J Zhang, F Wu, F Wei, W Han, X Xu… - …, 2023 - search.ebscohost.com
Abstract Simple Summary: Lymphatic vessels are low-pressure, blind-ended tubular
structures essential in maintaining tissue fluid homeostasis, immune cell transport, and lipid …

[HTML][HTML] Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect

H Deng, J Zhang, F Wu, F Wei, W Han, X Xu, Y Zhang - Cancers, 2023 - ncbi.nlm.nih.gov
The lymphatic system is a channel for fluid transport and cell migration, but it has always
been controversial in promoting and suppressing cancer. VEGFC/VEGFR3 signaling has …

Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect.

H Deng, J Zhang, F Wu, F Wei, W Han, X Xu, Y Zhang - Cancers, 2023 - europepmc.org
The lymphatic system is a channel for fluid transport and cell migration, but it has always
been controversial in promoting and suppressing cancer. VEGFC/VEGFR3 signaling has …

Current Status of Lymphangiogenesis: Molecular Mechanism, Immune Tolerance, and Application Prospect

H Deng, J Zhang, F Wu, F Wei, W Han, X Xu… - …, 2023 - pubmed.ncbi.nlm.nih.gov
The lymphatic system is a channel for fluid transport and cell migration, but it has always
been controversial in promoting and suppressing cancer. VEGFC/VEGFR3 signaling has …